12.12.2021, 956 Zeichen

Valneva: Valneva, an Austrian/French specialty vaccine company, today announced the signing of an advance purchase agreement with the Kingdom of Bahrain for the supply of one million doses of the Company’s inactivated COVID-19 vaccine candidate VLA2001. This is the second purchase agreement Valneva has secured for VLA2001 since reporting positive data for its Phase 3 clinical trial Cov-Compare. Valneva has initiated a rolling submission process with the Bahraini National Health Regulatory Authority (NHRA).  Franck Grimaud, Chief Business Officer of Valneva, commented, “We are grateful to the Bahraini government for their trust and confidence in our vaccine and are eager to work with them to start helping to address the pandemic evolution in the Middle-East. Subject to regulatory review and approval, we plan to start deliveries in the first quarter of 2022.”

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (08/12/2021)

Christian Drastil: Wiener Börse Plausch

Zertifikate Party Österreich: Volker Meinel, der Hebel- und Sekundärmarkt-Titelverteidiger (noch 5 Tage bis zum 20. Zertifikate Award 2026)

Bildnachweis

Aktien auf dem Radar:Polytec Group, Semperit, AT&S, Austriacard Holdings AG, Amag, Kapsch TrafficCom, Zumtobel, Rosenbauer, Rosgix, CA Immo, FACC, Reploid Group AG, Andritz, Mayr-Melnhof, Palfinger, EuroTeleSites AG, Fabasoft, Frequentis, Gurktaler AG Stamm, Porr, voestalpine, BKS Bank Stamm, CPI Europe AG, Österreichische Post, Telekom Austria, Infineon, IBM, Cisco, Nvidia, Fresenius Medical Care, Bayer.

---